MétaCan
Menu
Back to cohort

Polypharmacy in clozapine-treated patients: A retrospective analysis of 667 patients in Ottawa, Canada

2025· article· en· W4413140374 on OpenAlexaffabout
Nicholas Preobrazenski, Carrie Robertson, Helen Thai, Olabisi Owoeye

Bibliographic record

VenuePsychiatry Research · 2025
Typearticle
Languageen
FieldMedicine
TopicSchizophrenia research and treatment
Canadian institutionsMcGill UniversityRoyal Ottawa Mental Health CentreUniversity of Ottawa
Fundersnot available
KeywordsClozapinePolypharmacyMedicineSchizoaffective disorderAripiprazoleSchizophrenia (object-oriented programming)AntipsychoticRetrospective cohort studyPediatricsQuetiapineInternal medicinePsychiatryPsychosis

Abstract

fetched live from OpenAlex

• Clozapine polypharmacy was found in over 80 % of TRS patients in this sample. • Over 50 % of TRS patients received clozapine in combination with at least one other antipsychotic. • Schizoaffective diagnosis, older age and female sex were associated with increased polypharmacy risk. • Polypharmacy correlated with comorbid diabetes and respiratory disease. • Data from 667 clozapine-treated patients in Canada fills a key knowledge gap. Clozapine is the gold standard for treatment-resistant schizophrenia (TRS), yet only 40 % of patients respond. Clinicians often add other psychotropics despite limited evidence and possible harms. Canadian data on this practice remains sparse. We retrospectively reviewed charts of 667 adults prescribed clozapine between 2017-2020 in Ottawa, Canada. Clozapine augmentation was defined as prescription of ≥1 other psychotropic medication. Descriptive statistics summarized medication class frequences; X 2 or Wilcoxon tests assessed associations with demographic and clinical variables. After excluding four charts without medication data, 550/663 patients (83 %) received at least one add-on class (median 2 classes, IQR 1-3). Anti-psychotics were the commonest add-ons with 354 patients (53.4 % of all; 64.4 % of the augmented group) receiving clozapine plus another antipsychotic, most often aripiprazole (n=83). Valproate/divalproex was the commonest add-on (n=115). Clozapine with Paliperidone was the most frequent two - drug combination (n=29). Augmentation was more frequent in schizoaffective disorder than schizophrenia (91 vs. 81 %, p =0.010), in older adults (median 46 vs. 38 yrs, p <0.001), in females (88 vs. 81 %, p =0.028), and in patients with respiratory disease ( p =0.015) or diabetes ( p =0.019). Residence in supported or inpatient housing was also associated with augmentation ( p <0.001). Recent hospitalization, current smoking, and self-reported ethnicity showed no association with augmentation ( p ≥0.33). Clozapine polypharmacy is common in patients treated at this Canadian psychiatric hospital, with more than half of clozapine-treated patients receiving an additional antipsychotic. This high prevalence highlights a need for evidence-based guidelines and integrated monitoring to balance symptomatic benefit against additive pharmacologic risk in TRS.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.043
Threshold uncertainty score0.156

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.007
Science and technology studies0.0030.001
Scholarly communication0.0020.001
Open science0.0020.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.364
Teacher spread0.346 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venuePsychiatry ResearchSame topicSchizophrenia research and treatmentFrench-language works237,207